Vir Biotechnology, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US92764N1028
USD
8.82
0.05 (0.63%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
238.95
-0.03
64.07
0.24
1.21
3.03
12.37
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
238.95
-0.03
64.07
0.24
1.21
3.03
12.37
Raw Material Cost
2.80
2.81
2.92
2.99
2.93
2.87
3.57
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
30.20
23.34
23.62
22.23
22.28
23.94
26.70
Other Expenses
13.14
10.70
8.55
14.79
8.46
11.47
8.17
Total Expenditure (Excl Depreciation)
164.35
133.15
112.07
173.12
109.82
141.56
111.93
Operating Profit (PBDIT) excl Other Income
74.6
-133.2
-48
-172.89999999999998
-108.6
-138.5
-99.60000000000001
Other Income
8.52
6.93
7.47
9.13
11.01
12.22
13.65
Operating Profit (PBDIT)
85.91
-123.43
-37.64
-160.75
-94.68
-123.44
-83.02
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
-2.85
0.72
-2.53
0.78
-13.19
5.36
-18.77
Gross Profit (PBDT)
236.14
-2.84
61.15
-2.75
-1.71
0.17
8.80
Depreciation
2.80
2.81
2.90
3.00
2.92
2.87
2.89
Profit Before Tax
80.26
-125.53
-43.06
-162.97
-110.79
-120.95
-104.67
Tax
0.18
0.17
-0.14
0.17
0.17
0.02
-0.09
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
80.08
-125.69
-42.92
-163.14
-110.96
-120.97
-104.59
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
80.08
-125.69
-42.92
-163.14
-110.96
-120.97
-104.59
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
80.08
-125.69
-42.92
-163.14
-110.96
-120.97
-104.59
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
982.49
812.76
765.28
796.10
947.47
1,043.82
1,150.38
Earnings per share (EPS)
0.47
-0.85
-0.31
-1.17
-0.8
-0.88
-0.76
Diluted Earnings per share
0.47
-0.85
-0.31
-1.17
-0.8
-0.88
-0.76
Operating Profit Margin (Excl OI)
31.22%
0.0%
-74.92%
-72034.58%
-8946.38%
-4568.83%
-804.54%
Gross Profit Margin
34.76%
423151.72%
-62.68%
-66656.25%
-8885.58%
-3894.53%
-822.6%
PAT Margin
33.51%
0.0%
-66.99%
-67975.42%
-9139.87%
-3989.61%
-845.23%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2026 is 0.00% vs -100.00% in Mar 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is 163.72% vs -193.01% in Mar 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is 159.36% vs -189.14% in Mar 2026

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

Compare Quarterly Results Of Vir Biotechnology, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
238.95
0.00
238.95
Other Operating Income
0.00
0.00
0.00
Total Operating income
238.95
0.00
238.95
Raw Material Cost
2.80
0.04
2.76
6,900.00%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
99.20
-99.20
-100.00%
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
30.20
62.55
-32.35
-51.72%
Other Expenses
13.14
3.34
9.80
293.41%
Total Expenditure (Excl Depreciation)
164.35
195.21
-30.86
-15.81%
Operating Profit (PBDIT) excl Other Income
74.60
-195.21
269.81
138.22%
Other Income
8.52
5.79
2.73
47.15%
Operating Profit (PBDIT)
85.91
-189.38
275.29
145.36%
Interest
0.00
0.00
0.00
Exceptional Items
-2.85
0.00
-2.85
Gross Profit (PBDT)
236.14
-0.04
236.18
590,450.00%
Depreciation
2.80
0.04
2.76
6,900.00%
Profit Before Tax
80.26
-189.42
269.68
142.37%
Tax
0.18
0.00
0.18
Provisions and contingencies
0
0
0.00
Profit After Tax
80.08
-189.42
269.50
142.28%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
80.08
-189.42
269.50
142.28%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
80.08
-189.42
269.50
142.28%
Equity Capital
0
0
0.00
Face Value
0.00
0.01
0.00
Reserves
982.49
545.93
436.56
79.97%
Earnings per share (EPS)
0.47
-0.24
0.71
295.83%
Diluted Earnings per share
0.47
-0.24
0.71
295.83%
Operating Profit Margin (Excl OI)
31.22%
0.00%
0.00
31.22%
Gross Profit Margin
34.76%
0.00%
0.00
34.76%
PAT Margin
33.51%
0.00%
0.00
33.51%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 23.89 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 0.00% vs -100.00% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 19,808.33% vs -61.29% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 8.01 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 163.72% vs -193.01% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 172.16% vs 19.80% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 7.74 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 159.36% vs -189.14% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 173.23% vs 15.51% in Jun 2025

Quarterly - Interest
Markets Mojo
No Interest in the last few periods
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 31.22%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has improved from Jun 2025